Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy

AIM: Dolutegravir is associated with more weight gain than efavirenz in people starting antiretroviral therapy (ART). We investigated the concentration-response relationships of efavirenz and dolutegravir with weight gain. METHODS: We determined concentration-response relationships of dolutegravir a...

Descripción completa

Detalles Bibliográficos
Autores principales: Griesel, Rulan, Kawuma, Aida N, Wasmann, Roeland, Sokhela, Simiso, Akpomiemie, Godspower, Venter, WD Francois, Wiesner, Lubbe, Denti, Paolo, Sinxadi, Phumla, Maartens, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612404/
https://www.ncbi.nlm.nih.gov/pubmed/34954840
http://dx.doi.org/10.1111/bcp.15177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612404/
https://www.ncbi.nlm.nih.gov/pubmed/34954840
http://dx.doi.org/10.1111/bcp.15177

Ejemplares similares